News
Today’s White House MAHA Commission report is expected to pull punches on pesticide regulation as Bayer lobbies to limit ...
German pharmaceutical giant Bayer said Tuesday it had struck a deal valued at up to $1.3 billion (1.1 billion euros) with a US ...
Public and environmental health advocacy groups attacked the decision, saying it ignores established evidence.
Effective weed control between harvest and drilling is crucial to control yield-sapping grassweeds such as blackgrass, ...
Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...
Adaptability is the name of the game for farmers. There is a constant need to evolve to not only meet your yield goals but ...
Glyphosate, a key product that is used by a number of farmers, could be coming to an end. Bill Anderson, the CEO of Bayer, ...
Bayer’s Roundup pesticide is linked with cancer. Its fight to dodge accountability threatens to leave sick people holding the ...
This episode of Pharma Pulse covers Bayer’s $2.3 billion cost-cutting overhaul, promising Phase III results for Eli Lilly’s ...
The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...
Facing another 61,000 unresolved lawsuits claiming its weedkiller causes cancer, Bayer added $1.2 billion to its glyphosate ...
Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results